Qalsody

Saudi Food and Drug Authority has approved the registration of Qalsody (Tofersen) for ALS treatment.

SFDA approves registration of Qalsody for ALS treatment

  • ALS is a rare neurodegenerative disease that affects the nerve cells responsible for voluntary movement, gradually causing muscle weakness and leading to loss of mobility
By Arab News ·